Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 677-683

  Ferraro, Gabriella ^a   Annibale, Bruno ^b   Marignani, Massimo ^b   Azzoni, Cinzia ^a   D'Adda, Tiziana ^a   D'Ambra, Giancarlo ^b   Bordi, Cesare ^a   Delle Fave, Gianfranco ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CELL GROWTH; CLINICAL ARTICLE; DRUG EFFECT; ENTEROCHROMAFFIN CELL; FEMALE; GASTRIN RELEASE; HUMAN; HYPERGASTRINEMIA; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BIOPSY; CHROMOGRANIN A; CHROMOGRANINS; ENTEROCHROMAFFIN CELLS; FASTING; FEMALE; GASTRIC MUCOSA; GASTRINS; GASTRITIS, ATROPHIC; GASTROINTESTINAL AGENTS; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; SOMATOSTATIN;

EID: 0030063402     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.677     Document Type: Article

References (39)

1. Correa P. 1989 Chronic gastritis (non specific). In: Whitehead R, eds. Gastrointestinal and oesophageal pathology. Edinburgh: Churchill Livingstone; 402-420.
2. Solcia E, Bordi C, Creutzfeldt W, et al. 1988 Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 41:185-200.
3. Solcia E, Fiocca R, Villani L, et al. 1991 Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol. 26(Suppl 180):146-159.
4. Bordi C, Yu J-Y, Baggi MT, et al. 1991 Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 67:663-672.
5. Sipponen P, Kekki M, Haapakoski J, Ihamäki T, Siurala M. 1985 Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer. 35:173-177.
6. Borch K, Renvall H, Kullman E, Wilander E. 1987 Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis: a prospective analysis of 11 cases. Am J Surg Pathol. 11:435-444.
7. Sipponen P. 1994 Gastric cancer. A long-term consequence of Helicobacterpylori infection? Scand J Gastroenterol. 29(Suppl 201):24-27.
8. Bordi C, Costa A, Missale G. 1975 ECL cell proliferation and gastrin levels. Gastroenterology. 68:205-206.
9. Håkanson R, Sundler F. 1993 Regulation of gastric endocrine cell proliferation. In: Walsh JH, eds. Gastrin. New York: Raven Press; 307-318.
10. Bordi C, D'Adda T, Azzoni C, Pilato FP, Caruana P. 1995 Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol. 19[Suppl. 1]:S8-S19.
11. Bordi C. 1981 Non-antral gastric carcinoids and hypergastrinemia [Letter]. Arch Surg. 116:1238.
12. Larsson H, Carlsson E, Mattsson H, et al. 1986 Plasma gastrin and gastric entero-chromaffin like cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology. 90: 391-399.
13. Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW. 1992 Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology. 102:1409-1418.
14. Lamberts SWJ, Krenning E, Reubi JC. 1991 The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 12:450-482.
15. Ruszniewski P, Laucournet H, Elouaer-Blanc L, Mignon M, Bonfils S. 1988 Long-acting somatostatin (SMS 201-995) in management of Zollinger-Ellison syndrome: evidence for sustained efficacy. Pancreas. 3:145-152.
16. Meijer JL, Jansen JBMJ, Crobach LFSJ, Biemond I, Lamers CBHW. 1993 Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man. Gut. 34:1186-1190.
17. Annibale B, Delle Fave G, Azzoni C, et al. 1994 Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G cell hyperfunction. Alim Pharmacol Ther. 8:95-104.
18. Bordi C, Azzoni C, Pilato FP, et al. 1993 Morphometry of gastric endocrine cells in hypergastrinemic patients treated with the somatostatin analogue octreotide. Regul Pept. 47:307-318.
19. Whitehead R. 1973 Mucosal biopsies of the gastrointestinal tract. London: Saunders.
20. Tielemans Y, Willems G, Sundler F, Håkanson R. 1990 Self replication of enterochromaffin-like cells in the mouse stomach. Digestion. 45:138-146.
21. Delle Fave G, Kohn A, De Magistris L, et al. 1983 Effects of bombesin on gastric acid secretion in patients with duodenal ulcer. Gut. 24:231-235.
22. Misiewicz JJ, Tytgat G, Goodwin CS, Price A, Sipponen P, Strickland R. 1989 The Sidney sistem: a new classification of gastritis. In: eds. Working Party Reports of the 9th World Congress of Gastroenterology. Melbourne: Blackwell; 1-10.
23. D'Adda T, Corleto V, Pilato FP, et al. 1990 Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology. 99:17-26.
24. D'Adda T, Pilato FP, Lazzaroni M, Robutti F, Bianchi-Porro G, Bordi C. 1991 Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. A study in the oxyntic mucosa of duodenal ulcer patients. Gastroenterology. 100:1563-1570.
25. Loud AV, Anversa P. 1984 Morphometric analysis of biologic processes. Lab Invest. 50:250-261.
26. D'Adda T, Bertelé A, Pilato FP, Bordi C. 1989 Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach. Cell Tissue Res. 255:41-48.
27. Simonsson M, Eriksson S, Håkanson R, et al. 1988 Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol. 23: 1089-1099.
28. Bordi C, Ferrari C, D'Adda T, et al. 1986 Ultrastructural characterization of fundic endocrine cell hyperplasia associated with atrophic gastritis and hypergastrinemia. Virchows Arch A [Pathol Anat]. 409:335-347.
29. Cattan D, Roucayrol A-M, Launay JM, et al. 1989 Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology. 97:586-596.
30. Reubi JC, Waser B, Horisberger U, et al. 1992 Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from mastomys gastric tumors. Endocrinology. 131:166-172.
31. Prinz C, Sachs G, Walsh JH, Coy DH, Wu SV. 1994 The somatostatin receptor subtype on rat enterochromaffinlike cells. Gastroenterology. 107:1067-1074.
32. Kubota A, Yamada Y, Kagimoto S, et al. 1994 Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest. 93:1321-1325.
33. D'Adda T, Annibale B, Azzoni C, et al. 1994 Oxyntic endocrine cells cell of hypergastrinemic patients. Differential response to antrectomy or octreotide. Gastroenterology. 106:A805.
34. Bordi C, Pilato FP, Bertelé A, D'Adda T, Missale G. 1988 Expression of glycoprotein hormone alpha-subunit by endocrine cells of the oxyntic mucosa is associated with hypergastrinemia. Hum Pathol. 19:580-585.
35. Chen D, Uribe A, Håkanson R, Sundler F. 1992 Somatostatin cells in the oxyntic mucosa of hypo- or hyper-gastrinemic rats. Scand J Gastroenterol. 27:479-482.
36. Park J, Chiba T, Yokotani K, Delvalle J, Yamada T. 1989 Somatostatin receptors on canine fundic D-cells: evidence for autocrine regulation of gastric somatostatin. Am J Physiol. 257:G235-G241.
37. Ho KY, Weissberger AJ, Marbach P, Lazarus L. 1990 Therapeutic efficacy of the somatostatin analog SMS 201.995 (octreotide) in acromegaly. Ann Intern Med. 112:173-181.
38. Dowling RH, Hussaini SH, Murphy GM, Wass JAH. 1992 Gallstones during octreotide therapy. Metabolism. 41(Suppl 2):22-33.
39. Hussaini SH, Murphy GM, Kennedy C, Besser GM, Wass JAH, Dowling RH. 1994 The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology. 107:1503-1513.